Welcome to our dedicated page for Beneficient-A SEC filings (Ticker: BENF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Beneficient (BENF) SEC filings page brings together the company’s regulatory disclosures as a Nevada corporation listed on The Nasdaq Capital Market. Beneficient describes itself as a technology-enabled platform that provides exit opportunities, primary capital solutions, and related trust and custody services to holders of alternative assets, and its filings with the Securities and Exchange Commission offer detailed insight into how this business is structured and governed.
Through its registration statements, such as its S-1, Beneficient presents information about its capital structure, segments, and risk factors. Periodic reports referenced in its filings and press releases, including annual reports on Form 10-K and quarterly reports on Form 10-Q, discuss the performance of its Ben Liquidity and Ben Custody segments, the composition and diversification of its ExAlt loan portfolio, operating expenses, and capital and liquidity position.
The company’s current reports on Form 8-K provide event-driven disclosures on topics such as reverse stock split actions, notices from The Nasdaq Stock Market regarding listing compliance, unregistered sales of equity securities, financial results releases, and changes in board leadership. These 8-K filings also reference the trading symbols for Beneficient’s securities: BENF for its Class A common stock and BENFW for its warrants.
Proxy materials, including definitive proxy statements on Schedule DEF 14A, describe matters submitted to stockholders, such as approval of reverse stock splits and related adjustments to authorized share counts. Together, these filings document how Beneficient manages its equity structure, responds to listing requirements, and seeks stockholder approval for significant corporate actions.
On Stock Titan, Beneficient’s SEC filings are updated in near real time from EDGAR, and AI-powered summaries can help explain complex documents, highlight key terms in 10-K and 10-Q reports, and surface notable items from 8-Ks and proxy statements, making it easier to review BENF’s regulatory history.
Beneficient (NASDAQ:BENF) filed an 8-K announcing the closure of a primary capital transaction through its subsidiary on June 17, 2025. The company issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in exchange for a limited partner interest in an investment fund valued at $1.91 million.
The Series B-8 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3397 per share, subject to monthly resets and a floor price of $0.2548. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion. The preferred shares rank pari passu with common stock for dividends and liquidation rights.
Beneficient (NASDAQ:BENF) filed an 8-K announcing the closing of a significant equity transaction on June 17, 2025. The company issued 191,037 shares of Series B-8 Resettable Convertible Preferred Stock in exchange for acquiring a limited partner interest in an investment fund valued at $1.91 million.
The Series B-8 Preferred Stock is convertible into Class A Common Stock at an initial conversion price of $0.3397 per share, subject to monthly resets and a floor price of $0.2548. A maximum of 7,497,528 shares of Class A Common Stock may be issued upon conversion. The preferred shares will automatically convert on specific trigger events, including the fifth anniversary of issuance.